Murat Özbalak (Murat Ozbalak)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Hodgkin Lymphoma

Raman Spectroscopy

Top Venues

Analytical methods : advancing methods and applications

Expert review of hematology

Turkish journal of haematology : official journal of Turkish Society of Haematology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Burhan Ferhanoğlu, Murat Özbalak
Sequencing novel agents in the treatment of classical hodgkin lymphoma. Expert review of hematology (2023)
Murat Özbalak, Metban Güzel Mastanzade, Özden Özlük, Tarık Onur Tiryaki, Sevgi Kalayoğlu-Beşışık, Ezgi Pınar Özbalak, Tuğrul Elverdi, Ipek Yonal Hindilerden, Ali Yılmaz Altay, Gulcin Yegen, Ahmet Emre Eskazan, Muhlis Cem Ar, Mustafa Nuri Yenerel, Teoman Soysal, Meliha Nalçacı, Burhan Ferhanoğlu, Sevgi Kalayoglu Besisik
Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience Turkish journal of haematology : official journal of Turkish Society of Haematology 39 (4) (2022)
Kaan Batu Soysal, Seyma Parlatan, Metban Mastanzade, Murat Özbalak, Mustafa Nuri Yenerel, Mehmet Burçin Ünlü, Gunay Basar, Ugur Parlatan
Raman tweezers as an alternative diagnostic tool for paroxysmal nocturnal hemoglobinuria. Analytical methods : advancing methods and applications 13 (35) (2021)
Olga Meltem Akay Yanar, Murat Özbalak, Mustafa Pehlivan, Birol Yildiz, Ant Uzay, Tuğçe Nur Yiğenoğlu, Tuğrul Elverdi, Leylagul Kaynar, Orhan Ayyildiz, Ipek Yonal Hindilerden, Hasan Sami Goksoy, Sebnem Izmir Guner, Ahmet Kursad Gunes, Mehmet Sonmez, Meltem Kurt Yüksel, Sinem Civriz Bozdag, Zübeyde Nur Özkurt, Tayfur Toptas, Mehmet Hilmi Dogu, Ozan Salim, Guray Saydam, Irfan Yavasoglu, Meltem Ayli, Gulsum Ozet, Murat Albayrak, Elif Birtaş Ateşoğlu, Selami Kocak Toprak, Rahsan Yildirim, Özgür Mehta, Sevgi Kalayoglu Besisik, Meliha Nalçacı, Fevzi Altuntas, Burhan Ferhanoğlu
Brentuximab vedotin consolidation therapy after autologous stem-cell transplantation in patients with high-risk Hodgkin lymphoma: Multicenter retrospective study. Hematological oncology 39 (4) (2021)